• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物药对慢性心力衰竭心肌代谢的药理作用。

Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure.

机构信息

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.

出版信息

Chin J Integr Med. 2024 May;30(5):458-467. doi: 10.1007/s11655-023-3649-5. Epub 2023 Sep 26.

DOI:10.1007/s11655-023-3649-5
PMID:37750985
Abstract

Although there have been significant advances in the treatment of heart failure in recent years, chronic heart failure remains a leading cause of cardiovascular disease-related death. Many studies have found that targeted cardiac metabolic remodeling has good potential for the treatment of heart failure. However, most of the drugs that increase cardiac energy are still in the theoretical or testing stage. Some research has found that botanical drugs not only increase myocardial energy metabolism through multiple targets but also have the potential to restore the balance of myocardial substrate metabolism. In this review, we summarized the mechanisms by which botanical drugs (the active ingredients/formulas/Chinese patent medicines) improve substrate utilization and promote myocardial energy metabolism by activating AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptors (PPARs) and other related targets. At the same time, some potential protective effects of botanical drugs on myocardium, such as alleviating oxidative stress and dysbiosis signaling, caused by metabolic disorders, were briefly discussed.

摘要

尽管近年来心力衰竭的治疗取得了重大进展,但慢性心力衰竭仍然是心血管疾病相关死亡的主要原因。许多研究发现,靶向心脏代谢重构对心力衰竭的治疗具有良好的潜力。然而,大多数增加心脏能量的药物仍处于理论或测试阶段。一些研究发现,植物药不仅通过多个靶点增加心肌能量代谢,而且具有恢复心肌底物代谢平衡的潜力。在这篇综述中,我们总结了植物药(活性成分/配方/中药)通过激活 AMP 激活的蛋白激酶(AMPK)、过氧化物酶体增殖物激活受体(PPARs)和其他相关靶点来改善底物利用和促进心肌能量代谢的机制。同时,简要讨论了植物药对代谢紊乱引起的心肌氧化应激和失调信号等潜在的保护作用。

相似文献

1
Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure.植物药对慢性心力衰竭心肌代谢的药理作用。
Chin J Integr Med. 2024 May;30(5):458-467. doi: 10.1007/s11655-023-3649-5. Epub 2023 Sep 26.
2
AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.AMP 激活的蛋白激酶-α2 调节代谢转录因子雌激素相关受体-α的表达,该因子与心力衰竭的发展有关。
Hypertension. 2011 Oct;58(4):696-703. doi: 10.1161/HYPERTENSIONAHA.111.174128. Epub 2011 Aug 8.
3
Regulation of energy metabolism by combination therapy attenuates cardiac metabolic remodeling in heart failure.联合治疗通过调节能量代谢减轻心力衰竭中心脏代谢重构。
Int J Biol Sci. 2020 Oct 16;16(16):3133-3148. doi: 10.7150/ijbs.49520. eCollection 2020.
4
Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.心力衰竭中的心肌能量底物代谢:从途径到治疗靶点
Curr Pharm Des. 2015;21(25):3654-64. doi: 10.2174/1381612821666150710150445.
5
AMP-activated protein kinase in the control of cardiac metabolism and remodeling.AMP激活的蛋白激酶对心脏代谢和重塑的调控
Curr Heart Fail Rep. 2012 Sep;9(3):164-73. doi: 10.1007/s11897-012-0102-z.
6
A network pharmacology approach to discover action mechanisms of Yangxinshi Tablet for improving energy metabolism in chronic ischemic heart failure.基于网络药理学的方法探索养心氏片改善慢性缺血性心力衰竭能量代谢的作用机制。
J Ethnopharmacol. 2020 Jan 10;246:112227. doi: 10.1016/j.jep.2019.112227. Epub 2019 Sep 8.
7
Targeting myocardial substrate metabolism in heart failure: potential for new therapies.心力衰竭中心肌底物代谢的靶向治疗:新疗法的潜力。
Eur J Heart Fail. 2012 Feb;14(2):120-9. doi: 10.1093/eurjhf/hfr173.
8
Shengxian decoction protects against chronic heart failure in a rat model via energy regulation mechanisms.圣仙汤通过能量调节机制保护大鼠慢性心力衰竭。
BMC Complement Med Ther. 2023 Jun 17;23(1):200. doi: 10.1186/s12906-023-04035-3.
9
[New idea of treatment of heart failure with traditional Chinese medical].
Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(22):3210-2.
10
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure.AMPK 激活:从心脏损伤到心力衰竭过渡的预防性治疗靶点。
Cardiovasc Res. 2011 May 1;90(2):224-33. doi: 10.1093/cvr/cvr034. Epub 2011 Feb 1.

本文引用的文献

1
Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets.慢性心力衰竭药理学方法的新进展:新药与心血管靶点
Front Cardiovasc Med. 2023 Jun 2;10:1157472. doi: 10.3389/fcvm.2023.1157472. eCollection 2023.
2
PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response.PGC-1α是线粒体生命周期和活性氧应激反应的主要调节因子。
Antioxidants (Basel). 2023 May 10;12(5):1075. doi: 10.3390/antiox12051075.
3
Integrated Control of Fatty Acid Metabolism in Heart Failure.心力衰竭中脂肪酸代谢的综合调控
Metabolites. 2023 Apr 29;13(5):615. doi: 10.3390/metabo13050615.
4
Glycometabolism reprogramming: Implications for cardiovascular diseases.糖代谢重编程:对心血管疾病的影响。
Prog Biophys Mol Biol. 2023 May;179:26-37. doi: 10.1016/j.pbiomolbio.2023.03.003. Epub 2023 Mar 23.
5
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的心肌代谢组学。
Circulation. 2023 Apr 11;147(15):1147-1161. doi: 10.1161/CIRCULATIONAHA.122.061846. Epub 2023 Mar 1.
6
Comprehensive Analysis of Mitochondrial Dynamics Alterations in Heart Diseases.心脏疾病中线粒体动力学改变的综合分析。
Int J Mol Sci. 2023 Feb 8;24(4):3414. doi: 10.3390/ijms24043414.
7
Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy.缺血性心肌病中线粒体质量控制的分子机制。
Int J Biol Sci. 2023 Jan 1;19(2):426-448. doi: 10.7150/ijbs.76223. eCollection 2023.
8
Cardiac metabolism in HFpEF: from fuel to signalling.射血分数保留的心力衰竭中的心脏代谢:从燃料到信号传导
Cardiovasc Res. 2023 Feb 3;118(18):3556-3575. doi: 10.1093/cvr/cvac166.
9
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy.代谢性心肌病中的能量底物代谢和氧化应激。
J Mol Med (Berl). 2022 Dec;100(12):1721-1739. doi: 10.1007/s00109-022-02269-1. Epub 2022 Nov 17.
10
Lactate metabolism in human health and disease.人体健康与疾病中的乳酸代谢。
Signal Transduct Target Ther. 2022 Sep 1;7(1):305. doi: 10.1038/s41392-022-01151-3.